275 related articles for article (PubMed ID: 20620970)
21. Disease-specific complications of chronic lymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program; 2008; ():450-6. PubMed ID: 19074125
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphatic leukemia presenting as hemolytic anaemia.
Pavithran K; Thomas M; Vimall A; Krishnamohan VE
Indian J Med Sci; 1999 Nov; 53(11):490-2. PubMed ID: 10862272
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
[TBL] [Abstract][Full Text] [Related]
24. Retrospective Study of T Cell Leukaemia (Large Granular Lymphocyte Variant) in Dogs Associated with Suspected Immune-Mediated Cytopaenia(s) in the Absence of Peripheral Lymphocytosis.
Capasso A; Villers E; Elliott J; Ilchyshyn N; Hopkins I; Sanchez FV; Verganti S
Animals (Basel); 2023 Jan; 13(3):. PubMed ID: 36766246
[TBL] [Abstract][Full Text] [Related]
25. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Michallet AS; Rossignol J; Cazin B; Ysebaert L
Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ding W; Zent CS
Clin Adv Hematol Oncol; 2007 Apr; 5(4):257-61. PubMed ID: 17607284
[TBL] [Abstract][Full Text] [Related]
27. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
[TBL] [Abstract][Full Text] [Related]
28. The complement system in chronic lymphocytic leukemia: a possible role in autoimmune manifestations.
Lugassy G; Schlesinger M
Leuk Lymphoma; 1996 May; 21(5-6):501-3. PubMed ID: 9172817
[TBL] [Abstract][Full Text] [Related]
29. Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems.
deAndrés-Galiana EJ; Fernández-Martínez JL; Luaces O; Del Coz JJ; Huergo-Zapico L; Acebes-Huerta A; González S; González-Rodríguez AP
J Biomed Inform; 2016 Apr; 60():342-51. PubMed ID: 26956213
[TBL] [Abstract][Full Text] [Related]
30. Detection of red cell alloantibody prior to overflow phenomenon in a case of warm AIHA secondary to Chronic Lymphocytic Leukemia and Myasthenia Gravis: A case report.
Bava D; Asirvatham V; Mandal S; Rohila AK; Mittal S
Transfus Clin Biol; 2023 Nov; 30(4):449-453. PubMed ID: 37689387
[TBL] [Abstract][Full Text] [Related]
31. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
32. Management of chronic lymphocytic leukaemia.
Kalil N; Cheson BD
Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
[TBL] [Abstract][Full Text] [Related]
33. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.
Landgren O; Gridley G; Check D; Caporaso NE; Morris Brown L
Br J Haematol; 2007 Dec; 139(5):791-8. PubMed ID: 17941950
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of rituximab in the treatment of refractory chronic lymphocytic leukemia patient with bone marrow aplasia.
Marotta G; Lenoci M; Fabbri A; Tozzi M; Lauria F
Hematol J; 2002; 3(6):299-301. PubMed ID: 12522452
[TBL] [Abstract][Full Text] [Related]
35. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C
Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444
[No Abstract] [Full Text] [Related]
36. Chronic lymphocytic leukemia-associated pure red cell aplasia.
D'Arena G; Cascavilla N
Int J Immunopathol Pharmacol; 2009; 22(2):279-86. PubMed ID: 19505381
[TBL] [Abstract][Full Text] [Related]
37. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
[TBL] [Abstract][Full Text] [Related]
38. Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia.
Schliffke S; Akyüz N; Ford CT; Mährle T; Thenhausen T; Krohn-Grimberghe A; Knop S; Bokemeyer C; Binder M
Leukemia; 2016 Nov; 30(11):2232-2234. PubMed ID: 27220665
[No Abstract] [Full Text] [Related]
39. Autoimmune cytopenias in chronic lymphocytic leukemia.
Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
[TBL] [Abstract][Full Text] [Related]
40. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
Shirai T
Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
